GSK Consumer Healthcare names chief marketing officer
GSK Consumer Healthcare on Monday name Amardeep Kahlon to the role of chief marketing officer and vice president of U.S. marketing.
Kahlon will report to Colin Mackenzie, region head of the Americas, and become a member of his leadership team.
“I’m thrilled to have Amardeep back on our team in the U.S. His familiarity with our market, customers and brand teams will help ensure a smooth transition and keep us on track to deliver our KPIs for Innovation, Performance and Trust,” Mackenzie said.
Kahlon was formerly the vice president and global business leader for cold and flu in the respiratory category, where he was responsible for the global delivery of programs and innovation to drive growth on the Theraflu brand concept.
During his time in the business, Kahlon led a digital acceleration program to drive new content in support of Theraflu innovations.
Ananda Professional launches new CBD oil for pharmacies
CYNTHIANA, Ky. — Ananda Professional, a wholly owned subsidiary of Ecofibre, recently announced the launch of a Cannabidiol (CBD) oil product line that’s available exclusively in U.S. independent pharmacies.
The line includes for oral use, a 300ml and 600ml tincture and a 30 and 60 count, 15ml soft gel, as well as a 125mg salve for topical use.
“Pharmacists are considered the most trusted healthcare professional,” stated chief revenue officer Chuck Schneider, “They are often the first stop for patients and consumers seeking information about prescription and over-the-counter treatments. Most importantly, they are best equipped as they have an understanding of a patient’s therapy regiment.”
Added Ecofibre’s CEO Eric Wang, “Vertical integration and full control of the manufacturing process ensures federal compliancy. Ananda Professional adheres to the strict government guidelines outlined by section 7606 of the 2014 Farm Bill and we proudly guarantee this. Our product is also cGMP (Current Good Manufacturing Processes) compliant, ensuring product consistency, purity and potency.”
The company is also working to bridge the knowledge gap and confusion about what hemp-derived CBD is and isn’t.
Both hemp and marijuana are members of the cannabis sativa family, but marijuana contains high levels of the psychoactive compound, THC. Hemp contains less than 0.3 percent THC and high levels of CBD, the non-psychoactive compound with a vast array of therapeutic potential, the company stated.
“The endocannabinoid system (ECS) present in all humans is responsible for a host of homeostasis activities, including immune response, inflammation, sleep/wake cycle regulation, and mood. ECS receptors are found extensively throughout the body; in the brain, the lymphatic system, the digestive system, the reproductive system and more. CBD influences activity within the ECS, upregulating our endogenous neurotransmitters to promote a variety of therapeutic responses,” explained Ananda Professional’s medical director Alex Capano,
Ananda Professional conducts free webinars to help educate pharmacists and their staff on the ECS, CBD’s safety and efficacy profile and how CBD helps patients suffering from pain, inflammation (arthritis), sleep disorders, anxiety and other conditions.
The company noted that pharmacists and executives will have the opportunity to speak directly with Ananda Professional at Cardinal’s RBC conference in San Diego, June 26 to 30, and the National Community Pharmacy Association convention this October in Boston.
DarioHealth offers 2-way coaching in latest diabetes app update
DarioHealth last week introduced version 4.0 of its diabetes management app to support a two-way coaching chat platform that aims to improve user experience and the way diabetes is managed, as well as key architectural infrastructure advances that will pave the way for a membership service.
“This is a big milestone for DarioHealth and we are very proud of version 4.0, which comes complete with a slew of new usability and user experience features that enhance user-engagement,” Erez Raphael, chairman and CEO DarioHealth, said. “The impact of our new coaching and membership features continue to highlight how DarioHealth is disrupting the digital health arena, as we put an emphasis on our holistic diabetes coaching programs. Furthermore, with the imminent launch of our iPhone Lightning-compatible blood glucose monitoring system in the U.S. market, we expect additional market share as we now can cater to iPhone customers with our award-winning Dario app.”
Used in conjunction with the Dario Blood Glucose Monitoring System or as a standalone app, the mobile app also supplies an educational content library and a digital program that aims to help consumers simplify their diabetes management.